脂質ナノ粒子の市場規模、シェア、動向分析レポート：LNP別、分子別、用途別、適応症別、最終用途別、地域別、セグメント別予測、2025年～2030年

脂質ナノ粒子市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の脂質ナノ粒子市場は2030年までに15億4,000万米ドルに達すると予測され、予測期間中に13.64%のCAGRで成長すると予測されています。

脂質市場は、特に遺伝子治療、腫瘍学、ワクチンなどのセグメントにおける先進的ドラッグデリバリーシステムに対する需要の増加によって大きな成長を遂げています。LNPは、mRNA、siRNA、低分子を含む広範な治療用分子を、安定性を向上させ分解を抑えながら標的細胞に直接カプセル化して送達するための非常に効率的な方法を記載しています。公的機関と民間企業の両方による研究開発活動の急増とナノメディシンへの投資の拡大は、製薬・バイオテクノロジー部門全体でLNPベースの薬剤製剤の広範な採用を支える上で重要な役割を果たしています。

mRNAワクチンのLNPベースの送達システムを利用したCOVID-19ワクチンの開発は、パンデミック中に大きな注目と資源を集めました。ワクチンデリバリー技術への注目の高まりは、LNP製剤と製造能力への技術革新と投資を促進し、間接的に市場に利益をもたらしました。規制当局は、LNP技術を利用したものを含め、COVID-19治療やワクチンの審査・承認プロセスを迅速化しました。これによってCOVID-19治療の迅速な市場参入が促進された一方で、他の治療領域におけるLNPベースの製品の規制経路と基準を合理化する必要性が浮き彫りになり、将来の規制の枠組みや市場の力学を形成する可能性があります。

さらに、戦略的提携、脂質製剤の技術的進歩、精密医療に対する意識の高まりが引き続き市場の成長を後押ししています。企業は現在、標的送達、低毒性、ペイロードの汎用性向上を目的に設計された次世代LNPプラットフォームに投資しています。イオン化可能な脂質、脂質とポリマーのハイブリッドシステム、表面改質などの革新は、希少遺伝性疾患を含む複雑な疾患の治療におけるLNPの範囲を拡大しています。これらの開発は、有利な規制状況や個別化治療に対する需要の高まりと相まって、今後数年間、市場の力強い勢いを維持すると予想されます。

脂質ナノ粒子市場レポートのハイライト

• LNP別では、リポソームセグメントが2024年に最大の収益シェアで市場全体を支配しました。リポソームベースの医薬品の規制当局による承認と、化粧品や栄養補助食品用途での使用の拡大が、引き続き市場の成長を支えています。
• 分子別では、mRNAセグメントが2024年に最大の収益シェアで市場全体を支配し、予測期間中に最も速いCAGRで成長すると予想されます。製薬会社やバイオテクノロジー企業がmRNA治療への投資を増やしているため、最適化されたLNP送達システムの需要が高まり続け、市場成長に拍車をかけています。
• 2024年には、治療が用途セグメントで優位を占めました。これは、医薬品開発のための研究機関と産業参入企業の共同研究が増加していることと、政府からの資金援助が増加していることによる。
• 2024年には、がんが適応症セグメントを支配し、予測期間中に大きなCAGRを記録すると予想されています。がんに対する負担の増大とがん治療におけるLNPの可能性が、このセグメントにおける重要な研究開発の原動力となっています。
• 製薬・バイオテクノロジー企業が最終用途セグメントを支配し、学術・研究機関セグメントが予測期間中に最も速いCAGRを記録する見込みです。
• 感染症の負担が大きいこと、購買力平価が高いこと、質の高い医療に対する政府の支援があること、償還が可能であることなどの要因により、2024年の市場は北米が支配的でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • SWOT分析、要因別（政治・法律、経済技術）
  • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 脂質ナノ粒子市場：LNPビジネス分析

• セグメントダッシュボード
• 脂質ナノ粒子の全体的変動分析
• 世界の脂質ナノ粒子市場規模と動向分析（LNP別、2018～2030年）
• リポソーム
• 固体脂質ナノ粒子
• ナノ構造脂質キャリア
• その他

第5章 脂質ナノ粒子市場：分子ビジネス分析

• セグメントダッシュボード
• 脂質ナノ粒子の全体的変動分析
• 世界の脂質ナノ粒子市場規模と動向分析（分子別、2018～2030年）
• siRNA
• mRNA
• その他

第6章 脂質ナノ粒子市場：用途ビジネス分析

• セグメントダッシュボード
• 脂質ナノ粒子の全体的変動分析
• 世界の脂質ナノ粒子市場規模と動向分析（用途別、2018～2030年）
• 治療
• 研究

第7章 脂質ナノ粒子市場：適応症ビジネス分析

• セグメントダッシュボード
• 脂質ナノ粒子の全体的変動分析
• 世界の脂質ナノ粒子市場規模と動向分析（適応症別、2018～2030年）
• がん
• 感染症
• 血液疾患
• その他

第8章 脂質ナノ粒子市場：最終用途ビジネス分析

• セグメントダッシュボード
• 脂質ナノ粒子の全体的変動分析
• 世界の脂質ナノ粒子市場規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• 学術研究機関
• その他

第9章 脂質ナノ粒子市場：LNP、分子、用途、適応症、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測と動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業ポジション分析、2024年
• 企業プロファイル/上場企業
  • Merck KGaA
  • Evonik Industries AG
  • Gattefosse
  • FUJIFILM Pharmaceutical
  • Danaher（Precision NanoSystems）
  • Creative Biolabs
  • IOI Oleo GmbH
  • NOF Corporation
  • Lipoid GmbH
  • Cyman Chemical

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 4 Global lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 5 Global lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 6 Global lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 7 Global lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 8 Global lipid nanoparticle market, by region, 2018 - 2030 (USD Million)
• Table 9 North America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
• Table 10 North America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 11 North America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 12 North America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 13 North America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 14 North America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 15 U.S. lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 16 U.S. lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 17 U.S. lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 18 U.S. lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 19 U.S. lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 20 Canada lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 21 Canada lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 22 Canada lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 23 Canada lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 24 Canada lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 25 Mexico lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 26 Mexico lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 27 Mexico lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 28 Mexico lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 29 Mexico lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 30 Europe lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
• Table 31 Europe lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 32 Europe lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 33 Europe lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 34 Europe lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 35 Europe lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 36 UK lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 37 UK lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 38 UK lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 39 UK lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 40 UK lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 41 Germany lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 42 Germany lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 43 Germany lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 44 Germany lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 45 Germany lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 46 France lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 47 France lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 48 France lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 49 France lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 50 France lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 51 Italy lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 52 Italy lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 53 Italy lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 54 Italy lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 55 Italy lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 56 Spain lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 57 Spain lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 58 Spain lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 59 Spain lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 60 Spain lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 61 Denmark lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 62 Denmark lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 63 Denmark lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 64 Denmark lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 65 Denmark lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 66 Sweden lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 67 Sweden lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 68 Sweden lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 69 Sweden lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 70 Sweden lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 71 Norway lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 72 Norway lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 73 Norway lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 74 Norway lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 75 Norway lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 82 Japan lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 83 Japan lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 84 Japan lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 85 Japan lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 86 Japan lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 87 China lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 88 China lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 89 China lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 90 China lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 91 China lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 92 India lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 93 India lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 94 India lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 95 India lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 96 India lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 97 Australia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 98 Australia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 99 Australia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 100 Australia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 101 Australia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 102 Thailand lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 103 Thailand lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 104 Thailand lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 105 Thailand lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 106 Thailand lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 107 South Korea lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 108 South Korea lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 109 South Korea lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 110 South Korea lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 111 South Korea lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 112 Latin America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
• Table 113 Latin America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 114 Latin America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 115 Latin America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 116 Latin America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 117 Latin America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 118 Brazil lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 119 Brazil lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 120 Brazil lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 121 Brazil lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 122 Brazil lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 123 Argentina lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 124 Argentina lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 125 Argentina lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 126 Argentina lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 127 Argentina lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 134 South Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 135 South Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 136 South Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 137 South Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 138 South Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 144 UAE lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 145 UAE lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 146 UAE lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 147 UAE lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 148 UAE lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 149 Kuwait lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
• Table 150 Kuwait lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
• Table 151 Kuwait lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
• Table 152 Kuwait lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
• Table 153 Kuwait lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
• Table 154 Participant's overview
• Table 155 Financial performance
• Table 156 Key companies undergoing expansions
• Table 157 Key companies undergoing acquisitions
• Table 158 Key companies undergoing collaborations
• Table 159 Key companies launching new products
• Table 160 Key companies undertaking other strategies

List of Figures

• Fig. 1 Lipid nanoparticle market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Genomics - Industry value chain analysis
• Fig. 15 Lipid nanoparticle market driver analysis
• Fig. 16 Lipid nanoparticle market restraint analysis
• Fig. 17 Lipid nanoparticle market: Porter's analysis
• Fig. 18 Lipid nanoparticle market: LNP outlook and key takeaways
• Fig. 19 Lipid nanoparticle market: LNP market share analysis, 2023 - 2030
• Fig. 20 Global lipid nanoparticle by liposomes market, 2018 - 2030 (USD Million)
• Fig. 21 Global lipid nanoparticle by solid lipid nanoparticles market, 2018 - 2030 (USD Million)
• Fig. 22 Global lipid nanoparticle by nanostructured lipid carriers market, 2018 - 2030 (USD Million)
• Fig. 23 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
• Fig. 24 Lipid nanoparticle market: Molecule outlook and key takeaways
• Fig. 25 Lipid nanoparticle market: Molecule market share analysis, 2023-2030
• Fig. 26 Global lipid nanoparticle by siRNA market, 2018 - 2030 (USD Million)
• Fig. 27 Global lipid nanoparticle by mRNA market, 2018 - 2030 (USD Million)
• Fig. 28 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
• Fig. 29 Lipid nanoparticle market: Application outlook and key takeaways
• Fig. 30 Lipid nanoparticle market: Application market share analysis, 2023-2030
• Fig. 31 Global lipid nanoparticle by therapeutics market, 2018 - 2030 (USD Million)
• Fig. 32 Global lipid nanoparticle by research market, 2018 - 2030 (USD Million)
• Fig. 33 Lipid nanoparticle market: Indication outlook and key takeaways
• Fig. 34 Lipid nanoparticle market: Indication market share analysis, 2023-2030
• Fig. 35 Global lipid nanoparticle by cancer market, 2018 - 2030 (USD Million)
• Fig. 36 Global lipid nanoparticle by infectious diseases market, 2018 - 2030 (USD Million)
• Fig. 37 Global lipid nanoparticle by blood diseases market, 2018 - 2030 (USD Million)
• Fig. 38 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
• Fig. 39 Lipid nanoparticle market: End user outlook and key takeaways
• Fig. 40 Lipid nanoparticle market: end user market share analysis, 2023-2030
• Fig. 41 Global lipid nanoparticle by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 42 Global lipid nanoparticle by academic & research institutes market, 2018 - 2030 (USD Million)
• Fig. 43 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
• Fig. 44 Regional marketplace: Key takeaways
• Fig. 45 North America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 U.S. key country dynamics
• Fig. 47 U.S. lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Canada key country dynamics
• Fig. 49 Canada lipid nanoparticle market, 2018 - 2030 (USD Million)
• Fig. 50 Mexico key country dynamics
• Fig. 51 Mexico lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 52 Europe lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 53 UK key country dynamics
• Fig. 54 UK lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 55 Germany key country dynamics
• Fig. 56 Germany lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 57 France key country dynamics
• Fig. 58 France lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 59 Italy key country dynamics
• Fig. 60 Italy lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 61 Spain key country dynamics
• Fig. 62 Spain lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 63 Denmark key country dynamics
• Fig. 64 Denmark lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 65 Sweden key country dynamics
• Fig. 66 Sweden lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 67 Norway key country dynamics
• Fig. 68 Norway lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 69 Asia-Pacific lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 70 Japan key country dynamics
• Fig. 71 Japan lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 72 China key country dynamics
• Fig. 73 China lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 74 India key country dynamics
• Fig. 75 India lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 76 Australia key country dynamics
• Fig. 77 Australia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 78 Thailand key country dynamics
• Fig. 79 Thailand lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 80 South Korea key country dynamics
• Fig. 81 South Korea lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 82 Latin America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 83 Brazil key country dynamics
• Fig. 84 Brazil lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 85 Argentina key country dynamics
• Fig. 86 Argentina lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 87 MEA lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 88 South Africa key country dynamics
• Fig. 89 South Africa lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 90 Saudi Arabia key country dynamics
• Fig. 91 Saudi Arabia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 92 UAE key country dynamics
• Fig. 93 UAE lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 94 Kuwait key country dynamics
• Fig. 95 Kuwait lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 96 Key company categorization
• Fig. 97 Company market positioning
• Fig. 98 Market participant categorization
• Fig. 99 Strategy framework

Lipid Nanoparticle Market Growth & Trends:

The global lipid nanoparticle market is anticipated to reach USD 1.54 billion by 2030 and is projected to grow at a CAGR of 13.64% during the forecast period, according to a new report by Grand View Research, Inc. The lipid market has experienced significant growth driven by increasing demand for advanced drug delivery systems, particularly in the fields of gene therapy, oncology, and vaccines. LNPs offer a highly efficient method for encapsulating and delivering a wide range of therapeutic molecules-including mRNA, siRNA, and small molecules-directly to target cells with improved stability and reduced degradation. The surge in R&D activities and growing investment in nanomedicine by both public institutions and private players have played a critical role in supporting the widespread adoption of LNP-based drug formulations across the pharmaceutical and biotechnology sectors.

The development of COVID-19 vaccines that utilized LNP-based delivery systems for mRNA vaccines garnered significant attention and resources during the pandemic. This increased focus on vaccine delivery technologies has indirectly benefited the market by driving innovation and investment in LNP formulation and manufacturing capabilities. Regulatory agencies expedited the review and approval processes for COVID-19 therapeutics and vaccines, including those utilizing LNP technology. While this facilitated rapid market entry for COVID-19 treatments, it also underscored the need for streamlined regulatory pathways and standards for LNP-based products in other therapeutic areas, potentially shaping future regulatory frameworks and market dynamics.

Moreover, strategic collaborations, technological advancements in lipid formulation, and increased awareness of precision medicine continue to drive market growth. Companies are now investing in next-generation LNP platforms designed for targeted delivery, lower toxicity, and enhanced payload versatility. Innovations such as ionizable lipids, hybrid lipid-polymer systems, and surface modifications are expanding the scope of LNPs in treating complex diseases, including rare genetic disorders. These developments, coupled with a favorable regulatory landscape and rising demand for personalized treatments, are expected to sustain strong momentum in the market over the coming years.

Lipid Nanoparticle Market Report Highlights:

• Based on LNP, the liposomes segment dominated the overall market with the largest revenue share in 2024. Regulatory approvals of liposome-based drugs and their expanding use in cosmetic and nutraceutical applications continue to support market growth.
• In terms of molecule, the mRNA segment dominated the overall market with the largest revenue share in 2024 and is expected to grow at the fastest CAGR during the forecast period. As pharmaceutical companies and biotech firms increasingly invest in mRNA therapeutics, the demand for optimized LNP delivery systems continues to rise, fueling market growth.
• Therapeutics dominated the application segment in 2024 owing to the increasing collaborations between research institutions and industry players for drug development and growing government funding,
• In 2024, cancer dominated the disease indication segment and is expected to witness a significant CAGR over the forecast period. The rising cancer burden and the potential of LNPs in cancer treatment are driving significant research and development efforts in this area.
• Pharmaceutical & biotechnology companies dominated the end use segment and the academic & research institute segment is expected to register the fastest CAGR during the forecast period.
• North America dominated the market in 2024 owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. LNP
  • 1.2.2. Molecule
  • 1.2.3. Application
  • 1.2.4. Indication
  • 1.2.5. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Growing Demand for Drug Delivery Systems
    • 3.3.1.2. Rise in Pharmaceutical Research and Development
    • 3.3.1.3. Increasing Focus on Nanotechnology
    • 3.3.1.4. Government Support and Funding for RNA-based therapies
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High Development Costs
    • 3.3.2.2. Stringent Regulations Related to Approval and Commercialization
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Lipid Nanoparticle Market: LNP Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Lipid Nanoparticle Movement Analysis
• 4.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by LNP, 2018 to 2030 (USD Million)
• 4.4. Liposomes
  • 4.4.1. Global Liposomes Market, 2018 - 2030 (USD Million)
• 4.5. Solid Lipid Nanoparticles
  • 4.5.1. Global Solid Lipid Nanoparticles Market, 2018 - 2030 (USD Million)
• 4.6. Nanostructured Lipid Carriers
  • 4.6.1. Global Nanostructured Lipid Carriers Market, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 5. Lipid Nanoparticle Market: Molecule Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Lipid Nanoparticle Movement Analysis
• 5.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
• 5.4. siRNA
  • 5.4.1. Global siRNA Market, 2018 - 2030 (USD Million)
• 5.5. mRNA
  • 5.5.1. Global mRNA Market, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Lipid Nanoparticle Market: Application Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Lipid Nanoparticle Movement Analysis
• 6.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Therapeutics
  • 6.4.1. Global Therapeutics Market, 2018 - 2030 (USD Million)
• 6.5. Research
  • 6.5.1. Global Research Market, 2018 - 2030 (USD Million)

Chapter 7. Lipid Nanoparticle Market: Indication Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Lipid Nanoparticle Movement Analysis
• 7.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 7.4. Cancer
  • 7.4.1. Global Cancer Market, 2018 - 2030 (USD Million)
• 7.5. Infectious Diseases
  • 7.5.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
• 7.6. Blood Diseases
  • 7.6.1. Global Blood Diseases Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 8. Lipid Nanoparticle Market: End Use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Global Lipid Nanoparticle Movement Analysis
• 8.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Pharmaceutical & Biotechnology Companies
  • 8.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 8.5. Academic & Research Institutes
  • 8.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 9. Lipid Nanoparticle Market: Regional Estimates & Trend Analysis by LNP, Molecule, Application, Indication, & End Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. North America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Target Disease Prevalence
    • 9.3.2.4. Regulatory Framework
    • 9.3.2.5. U.S. Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Target Disease Prevalence
    • 9.3.3.4. Regulatory Framework
    • 9.3.3.5. Canada Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Target Disease Prevalence
    • 9.3.4.4. Regulatory Framework
    • 9.3.4.5. Mexico Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Target Disease Prevalence
    • 9.4.2.4. Regulatory Framework
    • 9.4.2.5. UK Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Target Disease Prevalence
    • 9.4.3.4. Regulatory Framework
    • 9.4.3.5. Germany Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Target Disease Prevalence
    • 9.4.4.4. Regulatory Framework
    • 9.4.4.5. France Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Target Disease Prevalence
    • 9.4.5.4. Regulatory Framework
    • 9.4.5.5. Italy Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Target Disease Prevalence
    • 9.4.6.4. Regulatory Framework
    • 9.4.6.5. Spain Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Target Disease Prevalence
    • 9.4.7.4. Regulatory Framework
    • 9.4.7.5. Denmark Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Target Disease Prevalence
    • 9.4.8.4. Regulatory Framework
    • 9.4.8.5. Sweden Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Target Disease Prevalence
    • 9.4.9.4. Regulatory Framework
    • 9.4.9.5. Norway Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Target Disease Prevalence
    • 9.5.2.4. Regulatory Framework
    • 9.5.2.5. Japan Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Target Disease Prevalence
    • 9.5.3.4. Regulatory Framework
    • 9.5.3.5. China Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Target Disease Prevalence
    • 9.5.4.4. Regulatory Framework
    • 9.5.4.5. India Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Target Disease Prevalence
    • 9.5.5.4. Regulatory Framework
    • 9.5.5.5. Australia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Target Disease Prevalence
    • 9.5.6.4. Regulatory Framework
    • 9.5.6.5. Thailand Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Target Disease Prevalence
    • 9.5.7.4. Regulatory Framework
    • 9.5.7.5. South Korea Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Target Disease Prevalence
    • 9.6.2.4. Regulatory Framework
    • 9.6.2.5. Brazil Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Target Disease Prevalence
    • 9.6.3.4. Regulatory Framework
    • 9.6.3.5. Argentina Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Target Disease Prevalence
    • 9.7.2.4. Regulatory Framework
    • 9.7.2.5. South Africa Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Target Disease Prevalence
    • 9.7.3.4. Regulatory Framework
    • 9.7.3.5. Saudi Arabia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Target Disease Prevalence
    • 9.7.4.4. Regulatory Framework
    • 9.7.4.5. UAE Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Target Disease Prevalence
    • 9.7.5.4. Regulatory Framework
    • 9.7.5.5. Kuwait Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. Merck KGaA
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. Evonik Industries AG
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Gattefosse
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. FUJIFILM Pharmaceutical
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. Danaher (Precision NanoSystems)
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Creative Biolabs
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. IOI Oleo GmbH
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. NOF Corporation
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Lipoid GmbH
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. Cyman Chemical
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives